Popular search terms:
Search Results
9 results found-
Resulting from these studies, as well as from long lasting clinical experience with fibrinogen products, dosage recommendations in the treatment of children are the same as for adults.
https://hcp.cslbehring.com.my/-/media/product/hcp-portal-in/product/hcp-portal-my/hcom-lpd_my_dec2022.pdf -
You and your healthcare professional have made an important decision to start Thrombosis (blood clotting) can occur with immune globulin products, treatment with HizentraTM.
https://hcp.cslbehring.com.my/-/media/product/hcp-asia-south-portal-sg/malaysia/hizentra-infusion-guide---my.pdf -
Patients with anti-IgA antibodies, in whom treatment with subcutaneous IgG products remains the only option, should be switched to Hizentra only under close medical supervision.
https://hcp.cslbehring.com.my/-/media/product/hcp-asia-south-portal-sg/malaysia/hizentra-pimy-jul2022.pdf -
The number of units of factor IX administered is expressed in International Units (IU), which are related to the current WHO standard for factor IX products.
https://hcp.cslbehring.com.my/-/media/product/hcp-asia-south-portal-sg/malaysia/idelvion-pi---malaysia-july-2021.pdf -
204 205 Haemolytic anaemia 206 IVIg products can contain blood group antibodies (e.g. anti-A and anti-B) which may act as 207 haemolysins and induce in vivo coating of red blood cells (RBC) with immunoglobulin, 208 causing a positive direct antiglobulin reaction (Coombs` test) and, rarely, haemolysis.
https://hcp.cslbehring.com.my/-/media/product/hcp-asia-south-portal-sg/malaysia/privigen-pimy-mar_2021.pdf